ReFlow Medical Inc.02.02.16
San Clemente, Calif.-based ReFlow Medical Inc. has been awarded U.S. Patent No. 9,204,893 entitled, “Systems, Methods, and Devices for Ablation, Crossing, and Cutting of Occlusions” which covers a key differentiating feature for its innovative Wingman Crossing Catheter technology.
The ReFlow family of peripheral and coronary crossing catheters are designed with an extendable bevel tip, and used in conjunction with steerable guidewires of the physician's choice to enable rapid, routine, off-the-shelf lesion crossing. ReFlow Medical recently announced an exclusive U.S. distribution agreement with Maquet Medical USA for the peripheral line of catheters.
“This marks an important milestone for our company,” said Isa Rizk, president and CEO of ReFlow Medical. “This granted patent helps protect the intellectual property of the company and further supports the differentiation of our product lines.”
The ReFlow Medical product portfolio was also recently expanded to include the Wingman 18 Crossing Catheter.
ReFlow Medical makes technologies for cardiovascular disease.
The ReFlow family of peripheral and coronary crossing catheters are designed with an extendable bevel tip, and used in conjunction with steerable guidewires of the physician's choice to enable rapid, routine, off-the-shelf lesion crossing. ReFlow Medical recently announced an exclusive U.S. distribution agreement with Maquet Medical USA for the peripheral line of catheters.
“This marks an important milestone for our company,” said Isa Rizk, president and CEO of ReFlow Medical. “This granted patent helps protect the intellectual property of the company and further supports the differentiation of our product lines.”
The ReFlow Medical product portfolio was also recently expanded to include the Wingman 18 Crossing Catheter.
ReFlow Medical makes technologies for cardiovascular disease.